Public consultation on draft guidance for introduction of HPV vaccines in EU countries
Focus on 9-valent HPV vaccine and vaccination of boys and people living with HIV
ECDC has previously produced two guidance documents on human papilloma virus (HPV) vaccination published in 2008 and 2012 that addressed questions related to the introduction of HPV immunisation in EU/EEA Member States. This guidance covers the following areas in relation to HPV vaccination: efficacy of the nine-valent HPV vaccine, HPV vaccination in people living with HIV and HPV vaccination in males and the cost-effectiveness of extending the HPV vaccination programme to include males. The document summarises evidence from studies included in the licensing file of HPV vaccines together with... 9 post-licensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV 10 vaccines observed during the pre- and post-licensing period.